ImageneBio, Inc.
IMANasdaqCIK 1835579HealthcareFiscal year ends Dec 31
Reports and events: 98 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-2816:24 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-148112 |
| 2024-05-1316:33 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058715 |
| 2024-04-2616:22 ET | DEF 14A | Proxy statementPeriod 2024-06-07 | 0001140361-24-022470 |
| 2024-03-1207:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-029651 |
| 2024-02-2116:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-041504 |
| 2024-01-1816:26 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-010227 |
| 2023-11-0907:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061535 |
| 2023-11-0907:09 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-061519 |
| 2023-10-1117:10 ET | 8-K | 5.07 Shareholder vote results | 0001140361-23-047880 |
| 2023-09-2516:05 ET | DEF 14A | Proxy statementPeriod 2023-10-11 | 0001140361-23-045091 |
| 2023-09-2116:52 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-23-000950 |
| 2023-09-1416:21 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-23-000929 |
| 2023-08-1007:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040943 |
| 2023-08-0708:02 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-204493 |
| 2023-06-3017:15 ET | 8-K | 3.01 Delisting notice | 0001193125-23-180591 |
| 2023-06-0916:26 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-164481 |
| 2023-05-1509:09 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-144274 |
| 2023-05-1506:04 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021909 |
| 2023-04-2808:17 ET | DEF 14A | Proxy statementPeriod 2023-06-09 | 0001193125-23-124483 |
| 2023-04-1709:14 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-103005 |
| 2023-03-1406:04 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-007681 |
| 2022-12-1916:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-308371 |
| 2022-11-2808:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-292953 |
| 2022-11-1009:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-282059 |
| 2022-11-0707:31 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-022323 |
| 2022-08-1106:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016600 |
| 2022-06-1007:46 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-171517 |
| 2022-05-1206:02 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009446 |
| 2022-04-2716:32 ET | DEF 14A | Proxy statementPeriod 2022-06-09 | 0001193125-22-123712 |
| 2022-04-1307:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-103598 |
| 2022-04-0607:04 ET | 8-K | 8.01 Other events | 0001193125-22-096765 |
| 2022-03-1706:31 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-003998 |
| 2022-02-2416:43 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-052216 |
| 2022-02-1117:12 ET | SC 13D | Ownership report, active investor | 0001387131-22-001711 |
| 2022-01-2807:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-020673 |
| 2022-01-2607:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-017680 |
| 2021-11-1016:39 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-326102 |
| 2021-11-1006:05 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-003871 |
| 2021-08-1616:45 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-21-000939 |
| 2021-08-1216:21 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043997 |
| 2021-08-1210:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-043726 |
| 2021-05-1316:15 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-027555 |
| 2021-05-1307:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-159837 |
| 2021-04-1507:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-117138 |
| 2021-04-1519:31 ET | SC 13D | Ownership report, active investor | 0000947871-21-000427 |
| 2021-03-3016:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-100292 |
| 2021-03-2208:51 ET | S-1/A | Registration statement, amended | 0001193125-21-088609 |
| 2021-03-0514:59 ET | S-1 | Registration statement | 0001193125-21-071313 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:13 ET. Listed shows no prices and gives no investment advice.